Patients with chronic fatigue syndrome benefit from cognitive behavior therapy

An im­munol­o­gy play­er and an Alzheimer’s biotech each have a big boost in cash — a mas­sive $1.1 bil­lion for ar­genx and $130 mil­lion for

The Eu­ro­pean Com­mis­sion made the rare de­ci­sion Mon­day not to adopt the neg­a­tive opin­ion of the Eu­ro­pean Med­i­cines Agency’s Com­mit­tee for Med­i­c­i­nal Prod­ucts for Hu­man